The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year

Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis

Preventive action involves imported and national items and reinforces rules for restricted disclosure to doctors and pharmacists

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

With limited spots available, Cannabis Connection 2025 will host the launch of the 5th Sechat Cannabis Guide and discussions on regulation, cultivation, and market

The largest strategic meeting on medical cannabis and hemp in Brazil takes place in São Paulo, bringing together researchers, entrepreneurs, and professionals who are shaping the country's green future

During the 4th Brazilian Medicinal Cannabis Congress, the president of Sindusfarma emphasized that only clear and responsible regulation can ensure quality, trust, and safe access to plant-derived products.

Studies show efficacy of cannabinoids in controlling inflammation, acne, and itching, while Anvisa evaluates expanding regulations for topical products

The Australian medicinal cannabis market is consolidating as an international reference and inspiring discussions in Brazil

Public consultation allows society to give opinions on the agency's priorities for the next two years; preliminary list does not include cannabis

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

Social Affairs Committee confirms Safatle, Cerqueira, and Cardoso's names, in a moment of important reforms at the agency

Social Affairs Committee to analyze four names for leadership positions in health agencies

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

Check out the confirmed names: Beatriz Marti Emygdio, Filipe Campos, Tarso Araujo, and João Paulo Silvério Perfeito will be among the specialists participating in the event in São Paulo